The oral cavity contains approximately 700 species of bacteria — forming the second most diverse microbial community in the human body after the gut. The oral microbiome is increasingly understood as an active participant in systemic health, with disruption of the healthy oral microbial balance (dysbiosis) now causally implicated in not only dental diseases but cardiovascular disease, diabetes, adverse pregnancy outcomes, and aspiration pneumonia. The mouth, uniquely among mucosal surfaces, contains both hard and soft tissue surfaces, creating multiple ecological niches with distinct microbial communities.
Caries and the Streptococcus mutans Model
The ecological plaque hypothesis provides the modern framework for dental caries: healthy dental plaque is a complex biofilm where acid-producing species (Streptococcus mutans, Lactobacillus) are maintained at low levels by competitive inhibition from health-associated species (Streptococcus sanguinis, Streptococcus gordonii). Frequent sugar exposure drives pH depression that selects for acid-tolerant cariogenic species — a reversible dysbiosis in early stages. This ecological model explains why fluoride, silver diamine fluoride, and xylitol all work: they disrupt the competitive advantage of acid-producing bacteria. Salivary diagnostics testing for S. mutans and Lactobacillus counts are commercially available and can stratify caries risk before visible disease appears.
Periodontal Disease: Keystone Pathogens
Periodontal disease — affecting 47% of American adults over 30 — involves a dysbiotic shift in the subgingival microbiome toward a community enriched in "red complex" anaerobes: Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola. P. gingivalis functions as a "keystone pathogen" — present at low abundance but exerting outsized influence on microbiome community structure by disabling host complement pathways and suppressing neutrophil function. The result is a microbial community that evades immune clearance and establishes chronic infection driving alveolar bone destruction. Salivary microbiome testing panels (OralDNA Labs, Dental DNA Solutions) can identify keystone pathogens before radiographic bone loss becomes evident, enabling preemptive antimicrobial and periodontal treatment.
Oral-Systemic Disease Connections
Periodontal disease is independently associated with: cardiovascular disease (HR 1.24–1.34 for CAD, 1.17 for stroke); diabetes (bidirectional relationship — periodontal inflammation worsens glycemic control, diabetes impairs periodontal immune response); preterm birth and low birth weight (OR 3.5–7.9 in some cohorts); and aspiration pneumonia in nursing home residents. The causal mechanisms include: hematogenous dissemination of oral bacteria to atherosclerotic plaques (oral bacteria detected in carotid and coronary plaque specimens), systemic cytokine elevation from periodontal inflammation driving insulin resistance, and direct aspiration of oral bacteria into the lung.
Oral Microbiome-Based Therapeutics
Emerging oral microbiome therapeutics include: probiotic oral rinses containing S. salivarius K12 (demonstrating reduction in oral VSCs causing halitosis and early data for periodontal benefit); arginine-containing dentifrices that raise plaque pH by stimulating arginine metabolism in competing health-associated bacteria; and bacteriocin-based therapies targeting S. mutans specifically without disrupting the broader microbiome. Dental practices committed to comprehensive oral health care should maintain dental supplies including periodontal probes, scalers, and antimicrobial agents supporting microbiome-guided clinical protocols.
